SG

Stefanie Grund

Associate Director CMC Programs at CureVac

Stefanie Grund has extensive work experience in various roles and positions. Stefanie began their career as a Research Trainee at Loyola University Chicago in 2001 and later joined Heidelberg University Biochemistry Center as a PhD student in 2003. After completing their PhD, they continued their work at Heidelberg University Biochemistry Center as a Postdoctoral fellow until 2008. Stefanie then moved to dkfz - German Cancer Research Center and worked as a Postdoctoral fellow from 2009 to 2011.

In 2012, Stefanie joined CureVac, where they held multiple positions. Stefanie started as a Scientist Enabling Technologies and worked there until 2015. From 2015 to 2017, they served as the Manager Early Process Development & Toxicology. After that, they worked as a Project Manager - Technical Project Lead, CMC from 2017 to 2021. Stefanie then took on the role of Project Manager - Manufacturing Project Lead, CMC from 2021 to 2022. Currently, they are working as a Senior Project Manager CMC & Deputy Group Lead at CureVac.

Stefanie Grund has a diverse educational background. Stefanie obtained a Diplom degree in Biologie from FAU Erlangen-Nürnberg from 1998 to 2003. Stefanie then pursued a PhD in Biology/Biochemistry at Heidelberg University, completing it from 2003 to 2008. Additionally, they earned a Betriebswirt (IWW) degree from FernUniversität in Hagen in 2010 and 2011. Stefanie Grund also holds a Basic certificate in project management from GPM Deutsche Gesellschaft für Projektmanagement e.V., obtained in 2015.

Location

Tübingen, Germany

Links

Previous companies


Org chart

No direct reports

Teams


Offices


CureVac

7 followers

CureVac is a global biopharmaceutical company in the field of messenger RNA (mRNA) technology, with more than 20 years of expertise in developing and optimizing the versatile biological molecule for medical purposes. The principle of CureVac’s proprietary technology is the use of non-chemically modified mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a broad range of diseases.


Industries

Headquarters

Tübingen, Germany

Employees

501-1,000

Links